Related Experiment Video

Updated: May 27, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Current therapies in the management of systolic and diastolic dysfunction

J M Rodgers1, S J Reeder

  • 1Southwestern Pennsylvania Cardiovascular Associates, Pittsburgh, Pa, USA.

Dimensions of Critical Care Nursing : DCCN
|November 15, 2011
PubMed

Insights

Systolic heart failure is a leading cause of hospitalization in older adults. Critical care nurses can improve patient outcomes by educating families on proper heart failure management and therapy adherence.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Nursing Science

Background:

  • Heart failure, particularly systolic dysfunction, is the primary reason for hospital admissions among the elderly.
  • The economic burden of heart failure management exceeds $10 billion annually.

Purpose of the Study:

  • To highlight the crucial role of critical care nurses in managing heart failure.
  • To emphasize the importance of differentiating between systolic and diastolic dysfunction.
  • To underscore the impact of patient and family education on disease progression.

Main Methods:

  • This study focuses on the educational and recognition roles of critical care nurses.
  • It involves assessing the nurse's ability to distinguish between systolic and diastolic heart failure.
  • It examines the effectiveness of patient and family teaching strategies.

Main Results:

  • Critical care nurses are pivotal in identifying systolic versus diastolic heart failure.
  • Effective patient and family education can mitigate disease progression.
  • Underuse or improper management of therapies significantly worsens heart failure outcomes.

Conclusions:

  • Nurses play an active role in heart failure care through education and early recognition.
  • Distinguishing between systolic and diastolic dysfunction is key for appropriate management.
  • Empowering patients and families with knowledge is essential for preventing heart failure progression and reducing hospitalizations.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...